A Study Evaluating JUVÉDERM® VOLUMA® XC Injectable Gel for Correction of Temple Hollowing in Adult Participants ≥ 22 Years Old
NCT04414397
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
205
Enrollment
INDUSTRY
Sponsor class
Conditions
Temple Hollowing
Interventions
DEVICE:
JUVÉDERM® VOLUMA® XC
OTHER:
No-treatment control
Sponsor
Allergan